// App-Quantinova.ai

SAT-129 : GROUP 2 INNATE LYMPHOID CELLS ARE REDUNDANT IN EXPERIMENTAL RENAL ISCHEMIA-REPERFUSION INJURY

Researchers

Presenter

  • G. CAMERON

Principal Investigators

  • S. Loering

  • A. Deshpande

  • S. Jiang

  • A. Molofsky

  • A. McKenzie

  • P. Hansbro

  • M. Starkey

Medical Centers

  • The University of Newcastle and Hunter Medical Research Institute, Priority Research Centre GrowUpWell- School of Biomedical Sciences and Pharmacy, New Lambton Heights, Australia

  • The John Hunter Children’s Hospital, Paediatric Urology, New Lambton Heights, Australia

  • Cambridge Biomedical Campus, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

  • Centenary Institute and School of Life Sciences- University of Technology, Centre for inflammation, Sydney, Australia

  • University of California, Department of Laboratory Medicine, San Francisco, Australia

  • National University- Department of Renal Medicine- The Canberra Hospital, Department of Immunology and Infectious Disease- John Curtin School of Medical Research, Canberra, Australia

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Cardiovascular (CVS)

Disease

  • Renal ischemia reperfusion injury

  • Acute renal failure

  • Coronary Artery Disease

Biomarkers

  • Interleukin 5

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved